对表皮生长因子受体2 (ErbB2) 的特定位点的糖化分析:探索治疗向的结构和功能
Naoki Fujitani1, Yasuaki Uehara1,2, Shigeru Ariki1,3
1Department of Biochemistry, Sapporo Medical University School of Medicine, S1W17, Chuo-ku, Sapporo 060-8556, Japan.
Glycobiology
|December 18, 2023
概括
这项研究绘制了表皮生长因子受体2 (ErbB2) 糖化图,揭示了特定的甘氨酸如何稳定ErbB2结构并影响癌症药物耐药性. 了解ErbB2糖形是开发向癌症治疗的关键.
科学领域:
- 生物化学和分子生物学
- 葡萄糖药物和癌症治疗药物
背景情况:
- 受体氨酸激酶 (RTK) 的糖化对癌症药物开发至关重要.
- 针对ErbB2等RTK的特定甘氨酸提供了克服药物耐药性的潜力.
- 需要对RTK糖形式进行详细的结构和功能表征.
研究的目的:
- 创建一个全面的表皮生长因子受体2 (ErbB2) 的糖形图谱.
- 阐明特定位点的糖化化特征及其功能影响.
- 探索ErbB2糖化在稳定受体中的作用及其作为治疗点的潜力.
主要方法:
- 质谱分析用于详细的甘氨酸分析.
- 分子动力学模拟以建模N-糖基化ErbB2结构.
- 对ErbB2突变体在特定的糖化位点缺乏的分析.
主要成果:
- 建立了ErbB2的详细的,特定地点的糖化概况 ("糖形图谱").
- 发现N-甘氨酸,特别是N124,可以稳定ErbB2结构.
- 在N124中缺乏N-糖化酶的ErbB2显示半衰期缩短和自化.
- 在ErbB2和EGFR之间观察到明显的糖化模式.
结论:
- ErbB2的糖化对其结构稳定性和功能产生重大影响.
- 在N124处的N-甘氨酸对ErbB2的稳定性和信号传输至关重要.
- 这些发现支持针对ErbB2阳性癌症开发针对糖甘的治疗策略.
相关概念视频
02:38Mitogens and the Cell Cycle
6.5K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.5K
01:27Transducer Mechanism: Enzyme-Linked Receptors
2.5K
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
2.5K